Stryker Expands Robotic-Assisted Surgery Footprint with Mako 4…

Event summary

Stryker launched Mako 4 SmartRobotics™ in India on October 4, 2026, marking its fourth-generation robotic-assisted joint replacement technology.
The platform integrates 3D CT-based planning, AccuStop™ haptic technology, and real-time intraoperative guidance for knee and hip replacements.
Mako 4 supports over 2.5 million procedures globally across 47 countries, with applications in total and partial knee, and total hip replacements.
Stryker aims to raise the standard of care and expand access for joint replacement patients in India's rapidly evolving healthcare landscape.

The big picture

Stryker's Mako 4 launch in India underscores the growing demand for advanced robotic-assisted joint replacement technologies in emerging markets. The move aligns with broader industry trends toward precision medicine and digital health integration, positioning Stryker to capture a larger share of India's expanding orthopedic surgery market. With over 2.5 million procedures supported globally, the Mako platform's expansion into India could further solidify Stryker's leadership in robotic-assisted orthopedic surgery.

What we're watching

Market Penetration: How quickly Stryker can scale Mako 4 adoption in India's competitive medical technology market.
Regulatory Dynamics: Whether India's healthcare regulations will support or hinder the widespread integration of robotic-assisted surgery.
Competitive Response: The pace at which competitors like Zimmer Biomet or Smith & Nephew introduce similar robotic solutions in emerging markets.